Trial intelligence / Profile preview

Magnesium sulfate added to tincture of opium and buprenorphine for dysmenorrhea pain and quality of life

TCTR20190329001Phase 0Completed

Sponsor
N/A
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 0, randomised, double-blind trial in dysmenorrhea comparing Magnesium sulfate arm with Placebo arm (2 arms). Primary endpoints: Pain intensity and Quality of life. Started Feb 2013; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

dysmenorrhea

Beyond the preview

Go deeper on TCTR20190329001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190329001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call